Zhigui Su

2.8k total citations
57 papers, 2.4k citations indexed

About

Zhigui Su is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Zhigui Su has authored 57 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Biomaterials and 12 papers in Biomedical Engineering. Recurrent topics in Zhigui Su's work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (15 papers) and Lipid Membrane Structure and Behavior (12 papers). Zhigui Su is often cited by papers focused on Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (15 papers) and Lipid Membrane Structure and Behavior (12 papers). Zhigui Su collaborates with scholars based in China, Pakistan and United States. Zhigui Su's co-authors include Qineng Ping, Can Zhang, Lingjing Xue, Minjie Sun, Yanyu Xiao, Minglei Chen, Yue Wu, Huipeng Li, Ying Xie and Hongzhi Qiao and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Zhigui Su

57 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhigui Su China 27 1.0k 912 858 406 331 57 2.4k
Nina Filipczak United States 23 1.0k 1.0× 864 0.9× 720 0.8× 203 0.5× 198 0.6× 44 2.2k
Adam W. G. Alani United States 26 716 0.7× 790 0.9× 567 0.7× 537 1.3× 187 0.6× 53 2.3k
Jinbing Xie China 23 1.1k 1.1× 962 1.1× 1.0k 1.2× 274 0.7× 181 0.5× 51 2.8k
Chaofeng Mu China 24 929 0.9× 684 0.8× 602 0.7× 288 0.7× 249 0.8× 53 2.0k
Ju Yeon Choi South Korea 30 895 0.9× 1.2k 1.3× 831 1.0× 541 1.3× 127 0.4× 51 2.4k
Rahul Maheshwari India 24 717 0.7× 871 1.0× 918 1.1× 410 1.0× 130 0.4× 85 2.3k
Yanzuo Chen China 27 1.2k 1.1× 1.6k 1.8× 1.1k 1.3× 340 0.8× 163 0.5× 42 2.9k
Jianping Zhou China 29 907 0.9× 801 0.9× 674 0.8× 274 0.7× 117 0.4× 62 2.2k
Xiang Gao China 31 1.1k 1.1× 758 0.8× 704 0.8× 166 0.4× 375 1.1× 95 2.8k
Wangwen Gu China 28 1.4k 1.4× 1.5k 1.6× 1.4k 1.7× 264 0.7× 192 0.6× 39 2.9k

Countries citing papers authored by Zhigui Su

Since Specialization
Citations

This map shows the geographic impact of Zhigui Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhigui Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhigui Su more than expected).

Fields of papers citing papers by Zhigui Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhigui Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhigui Su. The network helps show where Zhigui Su may publish in the future.

Co-authorship network of co-authors of Zhigui Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhigui Su. A scholar is included among the top collaborators of Zhigui Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhigui Su. Zhigui Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Shaowen, Jingjie Zhu, Yihan Peng, et al.. (2024). In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy. Angewandte Chemie International Edition. 64(11). e202421713–e202421713. 8 indexed citations
2.
Chen, Jiayin, Yan Chen, Ziqi Zhou, et al.. (2024). LNP-mRNA vaccine prevents type 1 diabetes in non-obese diabetes mice. Journal of Controlled Release. 375. 513–523. 11 indexed citations
3.
Xie, Shaowen, Jingjie Zhu, Yihan Peng, et al.. (2024). In Vivo Self‐Assembly of PROTACs by Bioorthogonal Chemistry for Precision Cancer Therapy. Angewandte Chemie. 137(11). 3 indexed citations
4.
Li, Xianglong, Wenmin Cao, Xinwu Wang, et al.. (2023). Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer. Journal of Controlled Release. 363. 221–234. 61 indexed citations
5.
Yin, Shi, et al.. (2023). An elastase-inhibiting, plaque-targeting and neutrophil-hitchhiking liposome against atherosclerosis. Acta Biomaterialia. 173. 470–481. 24 indexed citations
6.
Wang, Zibin, Yutong Wang, J. Su, et al.. (2022). Nano-sponge-like liposomes remove cholesterol crystals for antiatherosclerosis. Journal of Controlled Release. 349. 940–953. 16 indexed citations
7.
Wang, Cong, Yijun Chen, Lingjing Xue, et al.. (2022). Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis. Journal of Controlled Release. 343. 457–468. 14 indexed citations
8.
Li, Xiaoyu, et al.. (2022). Nanotechnology for Enhanced Cytoplasmic and Organelle Delivery of Bioactive Molecules to Immune Cells. Pharmaceutical Research. 39(6). 1065–1083. 4 indexed citations
9.
Zhang, Cheng, Caoyun Ju, Zhigui Su, et al.. (2019). Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. European Journal of Pharmaceutical Sciences. 134. 233–245. 66 indexed citations
10.
He, Yongju, Zhigui Su, Lingjing Xue, Hui Xu, & Can Zhang. (2016). Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. Journal of Controlled Release. 229. 80–92. 108 indexed citations
11.
Xu, Yurui, Sajid Asghar, Hongying Li, et al.. (2016). Preparation of a paclitaxel-loaded cationic nanoemulsome and its biodistribution via direct intratumoral injection. Colloids and Surfaces B Biointerfaces. 142. 81–88. 23 indexed citations
12.
Meng, Fanfei, Sajid Asghar, Shiya Gao, et al.. (2015). A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease. Colloids and Surfaces B Biointerfaces. 134. 88–97. 141 indexed citations
13.
Hao, Meixi, et al.. (2015). Novel nonsecosteroidal VDR ligands with phenyl-pyrrolyl pentane skeleton for cancer therapy. European Journal of Medicinal Chemistry. 107. 48–62. 8 indexed citations
14.
Qiao, Hongzhi, Minjie Sun, Zhigui Su, et al.. (2014). Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan. Biomaterials. 35(25). 7157–7171. 106 indexed citations
15.
Su, Zhigui, Minglei Chen, Yanyu Xiao, et al.. (2014). ROS-triggered and regenerating anticancer nanosystem: An effective strategy to subdue tumor's multidrug resistance. Journal of Controlled Release. 196. 370–383. 99 indexed citations
16.
17.
Su, Zhigui, Yanyu Xiao, Minjie Sun, et al.. (2013). Effect of octreotide surface density on receptor-mediated endocytosis in vitro and anticancer efficacy of modified nanocarrier in vivo after optimization. International Journal of Pharmaceutics. 447(1-2). 281–292. 34 indexed citations
18.
Li, Sai, Zhigui Su, Minjie Sun, et al.. (2012). An arginine derivative contained nanostructure lipid carriers with pH-sensitive membranolytic capability for lysosomolytic anti-cancer drug delivery. International Journal of Pharmaceutics. 436(1-2). 248–257. 33 indexed citations
19.
Xiao, Yanyu, Qineng Ping, Zhigui Su, Hongying Li, & Jiangxiu Niu. (2011). Preparation and pharmacokinetics in beagle dogs of once-a-day tetramethylpyrazine phosphate sustained-release pellets. Drug Development and Industrial Pharmacy. 38(3). 301–306. 4 indexed citations
20.
Sun, Minjie, Yu Wang, Jie Shen, et al.. (2010). Octreotide-modification enhances the delivery and targeting of doxorubicin-loaded liposomes to somatostatin receptors expressing tumorin vitroandin vivo. Nanotechnology. 21(47). 475101–475101. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Filipczak Breakdown of academic impact, for papers by Adam W. G. Alani Breakdown of academic impact, for papers by Jinbing Xie Breakdown of academic impact, for papers by Chaofeng Mu Breakdown of academic impact, for papers by Ju Yeon Choi Breakdown of academic impact, for papers by Rahul Maheshwari Breakdown of academic impact, for papers by Yanzuo Chen Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Xiang Gao Breakdown of academic impact, for papers by Wangwen Gu
Rankless by CCL
2026